Wellington Management Group LLP boosted its stake in Humana Inc. (NYSE:HUM – Free Report) by 7.3% in the 2nd quarter, Holdings Channel.com reports. The firm owned 765,355 shares of the insurance provider’s stock after acquiring an additional 52,004 shares during the quarter. Wellington Management Group LLP’s holdings in Humana were worth $304,014,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Humana during the second quarter worth $4,138,160,000. Pzena Investment Management LLC acquired a new stake in shares of Humana during the 2nd quarter valued at $1,749,014,000. Capital International Investors boosted its holdings in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares in the last quarter. Norges Bank bought a new stake in Humana during the 4th quarter worth $456,632,000. Finally, Franklin Resources Inc. grew its position in Humana by 914.5% during the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock worth $321,613,000 after acquiring an additional 1,131,893 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have commented on HUM shares. Weiss Ratings upgraded Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 14th. TD Cowen boosted their price target on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. UBS Group started coverage on Humana in a research note on Thursday, July 30th. They issued a “buy” rating for the company. Barclays raised their price objective on shares of Humana from $344.00 to $407.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Finally, Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $403.91.
Humana Stock Up 0.4%
Shares of HUM opened at $386.92 on Monday. The stock’s 50-day moving average price is $385.60 and its two-hundred day moving average price is $289.17. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The company has a market capitalization of $46.46 billion, a PE ratio of 36.61, a PEG ratio of 2.20 and a beta of 0.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter in the prior year, the firm posted $6.27 earnings per share. The business’s quarterly revenue was up 26.2% on a year-over-year basis. On average, analysts anticipate that Humana Inc. will post 9.12 EPS for the current year.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
